# PhaseBio Pharmaceuticals

**Canonical:** https://apis.io/providers/phasebio-pharmaceuticals/  
**Website:** https://phasebio.com  
**APIs profiled:** 0

PhaseBio Pharmaceuticals develops innovative therapies focused on cardiovascular and metabolic diseases, aiming to improve patient outcomes. The company’s mission, reflected in its tagline “Take It To Heart,” emphasizes commitment to advancing science and delivering impactful treatments.

## Kin Score — 5.8 / 100 (minimal)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 10.5 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 9.8 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Phasebio Pharmaceuticals Domain Security** — TLSv1.3

## Tags

Company, Biotechnology, Cardiovascular, Therapeutics, ClinicalTrials

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/phasebio-pharmaceuticals/). Scores are computed from the provider's own public artifacts under a published rubric.